TissueForm, Inc
TissueForm Inc. is a biomedical technology company specializing in the design, development, bioengineering, and fabrication of natural, tissue-based biomaterials. Their mission is to harness the restorative power of the extracellular matrix to heal large injuries or defects, improving the quality of life for individuals affected by volumetric tissue loss. They focus on creating acellular, bio-inspired biomaterials that promote healing, tissue regeneration, and integration with host tissue, with applications in regenerative medicine, 3D-bioprinting, and implantable medical devices.
Industries
Nr. of Employees
small (1-50)
TissueForm, Inc
Products
Acellular ECM-derived injectable dermal filler
An injectable dermal filler composed of acellular extracellular matrix powder embedded in a hyaluronic acid hydrogel that crosslinks at body temperature to provide immediate volumetric correction and promote regenerative tissue deposition.
Acellular ECM-derived injectable dermal filler
An injectable dermal filler composed of acellular extracellular matrix powder embedded in a hyaluronic acid hydrogel that crosslinks at body temperature to provide immediate volumetric correction and promote regenerative tissue deposition.
Services
Supply of acellular tissue-derived biomaterials
Provision of natural replacement biomaterials composed of acellular tissue particles embedded in hydrogel for research or translational use.
Collaborative biomaterial development and research partnerships
Joint development projects with academic or industry partners to adapt platform materials for specific tissue applications, including development of research-grade bioinks.
Supply of acellular tissue-derived biomaterials
Provision of natural replacement biomaterials composed of acellular tissue particles embedded in hydrogel for research or translational use.
Collaborative biomaterial development and research partnerships
Joint development projects with academic or industry partners to adapt platform materials for specific tissue applications, including development of research-grade bioinks.
Expertise Areas
- Biomaterial design and fabrication
- Acellular extracellular matrix therapies
- Regenerative medicine for volumetric tissue loss
- 3D bioprinting bioink development
Key Technologies
- Extracellular matrix (ECM)-based biomaterials
- In situ crosslinkable hydrogels
- Acellular particle fabrication
- Retention of tissue-specific growth factors